Erratum to "Effects of polymorphisms in endothelial nitric oxide synthase and folate metabolizing genes on the concentration of serum nitrate, folate, and plasma total homocysteine after folic acid supplementation: A double-blind crossover study" [Nutrition, 31, 2, (2015), 337-344] Doi: 10.1016/j.nut.2014.08.009;Effects of polymorphisms in endothelial nitric oxide synthase and folate metabolizing genes on the concentration of serum nitrate, folate, and plasma total homocysteine after folic acid supplementation: A double-blind crossover study

Nutrition

Volumn 31, Issue 2, 2015, Pages 337-344

  Cabo, Rona ^a   Hernes, Sigrunn ^a   Slettan, Audun ^a   Haugen, Margaretha ^a   Ye, Shu ^b   Blomhoff, Rune ^c,d   Mansoor, M Azam ^a  

^a UNIVERSITY OF AGDER   (Norway)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF OSLO   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Genetic polymorphisms; HPLC; Plasma total homocysteine; Serum folate; Serum nitrate

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; FOLIC ACID; HOMOCYSTEINE; NITRATE; PLACEBO; ARGININE; CARBOHYDRATE DIET; FAT INTAKE; NITRIC ACID DERIVATIVE; NOS3 PROTEIN, HUMAN; PROTEIN INTAKE; PYRIDOXINE;

ARTICLE; BLOOD SAMPLING; CARBOHYDRATE INTAKE; CENTRIFUGATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DHFR GENE; DOUBLE BLIND PROCEDURE; ENOS GENE; FAT INTAKE; FOLATE METABOLISM; FOLATE METABOLIZING GENE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MTHFR C GENE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VITAMIN INTAKE; ADMINISTRATION AND DOSAGE; BLOOD; CARBOHYDRATE DIET; DIET SUPPLEMENTATION; DOSE RESPONSE; GENETICS; GENOTYPING TECHNIQUE; METABOLISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ARGININE; CROSS-OVER STUDIES; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY PROTEINS; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FOLIC ACID; GENE FREQUENCY; GENOTYPING TECHNIQUES; HEALTHY VOLUNTEERS; HOMOCYSTEINE; HUMANS; NITRATES; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, SINGLE NUCLEOTIDE; VITAMIN B 6;

EID: 84920929689     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2015.04.001     Document Type: Erratum

References (49)

1. Moncada S., Higgs E.A. The l-arginine-nitric oxide pathway. N Engl J Med 1993, 329:2002-2012.
2. Vallance P., Chan N. Endothelial function and nitric oxide: clinical relevance. Heart 2001, 85:342-350.
3. Marroni A.S., Metzger I.F., Souza-Costa D.C., Nagassaki S., Sandrim V.C., Correa R.X., et al. Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms. Nitric Oxide 2005, 12:177-182.
4. Nakayama M., Yasue H., Yoshimura M., Shimasaki Y., Kugiyama K., Ogawa H., et al. T-786->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999, 99:2864-2870.
5. Hingorani A.D., Liang C.F., Fatibene J., Lyon A., Monteith S., Parsons A., et al. A common variant of the endothelial nitric oxide synthase (Glu298->Asp) is a major risk factor for coronary artery disease in the UK. Circulation 1999, 100:1515-1520.
6. Miyamoto Y., Saito Y., Kajiyama N., Yoshimura M., Shimasaki Y., Nakayams M., et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998, 32:3-8.
7. Wang X.L., Sim A.S., Badenhop R.F., McCredie R.M., Wilcken D.E. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 1996, 2:41-45.
8. Uwabo J., Soma M., Nakayama T., Kanmatsuse K. Association of a variable number of tandem repeats in the endothelial constitutive nitric oxide synthase gene with essential hypertension in Japanese. Am J Hypertens 1998, 11:125-128.
9. Stroes E.S.G., van Faassen E.E., Yo M., Martasek P., Boe P., Govers R., et al. Folic acid reverts dysfunction of endothelial nitric oxide synthase. Circ Res 2000, 86:1129-1134.
10. Mansoor M.A., Kristensen O., Hervig T., Stakkestad J.A., Berge T., Drabløs P.A., et al. Relationship between serum folate and plasma nitrate concentrations: possible clinical implications. Clin Chem 2005, 51:1266-1268.
11. Matthews R.G., Kaufman S. Characterization of the dihydropterin reductase activity of pig liver methylenetetrahydrofolate reductase. JBC 1980, 255:6014-6017.
12. Rao G.N., Cotlier E. Enzymatic activity of quinonoid dihydropterin reductase and tetrahydropeterin content in human ocular tissues and senile cataracts. Exp Eye Res 1985, 40:601-607.
13. Chalupsky K., Cai H. Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 2005, 102:9056-9061.
14. Moens A.L., Kass D.A. Tetrahydrobiopterin and cardiovascular disease. Arterioscler Thromb Vasc Biol 2006, 26:2439-2444.
15. Charasson V., Hillaire-Buys D., Solassol I., Laurand-Quancard A., Pinguet F., Le Morvan V., et al. Involvement of gene polymorphisms of the folate pathway enzymes in gene expression and anticancer drug sensitivity using the NCI-60 panel as a model. Eur J Cancer 2009, 45:2391-2401.
16. Forges T., Monnier-Barbarino P., Alberto J.M., Guéant-Rodriguez R.M., Daval J.L., Guéant J.L. Impact of folate and homocysteine metabolism on human reproductive health. Hum Reprod Update 2007, 13:225-238.
17. Skibola C.F., Smith M.T., Hubbard A., Shane B., Roberts A.C., Law G.R., et al. Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood 2002, 99:3786-3791.
18. Dhillon B., Badiwala M.V., Maitland A., Rao V., Li S.H., Verma S. Tetrahydrobiopterin attenuates homocysteine induced endothelial dysfunction. Mol Cell Biochem 2003, 247:223-227.
19. Danishpajooh I.O., Gudi T., Chen Y., Kharitonov V.G., Sharma V.S., Boss G.R. Nitric oxide inhibits methionine synthase activity invivo and disrupts carbon flow through the folate pathway. J Biol Chem 2001, 276:27296-27303.
20. Liu X., Miller M.J.S., Joshi M.S., Sadowska-Krowicka H., Clark D.A., Lancaster J.R. Diffusion-limited reaction of free nitric oxide with erythrocytes. J Biol Chem 2008, 273:18709-18713.
21. Weitzberg E., Lundberg J.O. Novel aspects of dietary nitrate and human health. Annu Rev Nutr 2013, 33:129-159.
22. Hobbs D.A., George T.W., Lovegrove J.A. The effects of dietary nitrate on blood pressure and endothelial function: a review of human intervention studies. Nutr Res Rev 2013, 26:210-222.
23. Jiang H., Torregrossa A.C., Parthasaathy D.K., Bryan N.S. Natural product nitric oxide chemistry: new activity of old medicines. Evid Based Complement Alternat Med 2012, 2012:1-9.
24. Carlström M., Liu M., Yang T., Zollbrecht C., Huang L., Peleli M., et al. Crosstalk between nitrate-nitrite-NO and NO synthase pathways in control of vascular NO homeostasis. Antioxidant & Redox Signaling 2013, 10.1089/ars.2013.5481.
25. Omar S.A., Webb A.J. Nitrite reduction and cardiovascular protection. J Mol and Cell Cardiol 2014, 73:57-69.
26. Kapil V., Weitzberg E., Lundberg J.O., Ahluwalia A. Clinical evidence demonstrating the utility of inorganic nitrate in cardiovascular health. Nitric Oxide 2014, 38:45-57.
27. Gilchrist M., Winyard P.G., Aizawa K., Anning C., Shore A., Benjamin N. Effect of dietary nitrate on blood pressure, endothelial function, and insulin sensitivity in type 2 diabetes. Free Radical Biol Med 2013, 60:89-97.
28. Larsen F.J., Schiffer T.A., Ekblom B., Mattasson M.P., Checa A., Wheelock C.E., et al. Dietary nitrate reduces resting metabolic rate: a randomized, crossover study in humans. Am J Clin Nutr 2014, 99:843-850.
29. Mansoor M.A., Svardal A.M., Ueland P.M. Determination of the invivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal Biochem 1992, 200:218-229.
30. Larsen T.L., Nilsen V., Andersen D.O., Francis G., Rustad P., Mansoor M.A. Comparison of high-pressure liquid chromatography (HPLC) and Griess reagent-spectroscopic methods for the measurement of nitrate in serum from healthy individuals in the Nordic countries. Clin Biochem 2008, 41:1474-1481.
31. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215.
32. Johnson W.G., Stenroos E.S., Spychala J.R., Chatkupt S., Ming S.X., Buyske S. New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): a risk factor for spina bifida acting in mothers during pregnancy. Am J Med Genet A 2004, 124A:339-345.
33. Hernes S., Cabo R.N., Mansoor M.A., Haugen M. Eating patterns are associated with biomarkers in selected population of university students and employees. J Nutr Sci 2012, 1:1-8.
34. Brown K.S., Kluijtmans L.A., Young I.S., Woodside J., Yarnell J.W., McMaster D., et al. Genetic evidence that nitric oxide modulates homocysteine: the NOS3 894 TT genotype is a risk factor for hyperhomocystenemia. Arterioscler Thromb Vasc Biol 2003, 23:1014-1020.
35. Brown K.S., Kluijtmans L.A., Young I.S., Murray L., McMaster D., Woodside J.V., et al. The 5,10-methylenetetrahydrofolate reductase C677 T polymorphism interacts with smoking to increase homocysteine. Atherosclerosis 2004, 174:315-322.
36. Moat S.J., Lang D., McDowell I.F., Clarke Z.L., Madhavan A.K., Lewis M.J., et al. Folate, homocysteine, endothelial function and cardiovascular disease. JNutr Biochem 2004, 15:64-79.
37. Fatini C., Sofi F., Gori A.M., Sticchi E., Marcucci R., Lenti M., et al. Endothelial nitric oxide synthase -786 T>C, but not 894 G>T and 4 b4 a, polymorphism influences plasma homocysteine concentrations in persons with normal vitamin status. Clin Chem 2004, 51:1159-1164.
38. Heil S.G., Den Heijer M., Van Der Rijt-Pisa B.J., Kluijtmans L.A., Blom H.J. The 894 G > T variant of endothelial nitric oxide synthase (eNOS) increases the risk of recurrent venous thrombosis through interaction with elevated homocysteine levels. J Thromb Haemost 2004, 2:750-753.
39. Shim S.H., Yoon T.K., Cha D.H., Han W.B., Choi D.H., Kim N.K. Endothelial Nitric Oxide Synthase (eNOS) gene polymorphisms in spontaneously aborted embryos. Genes Genomics 2010, 32:283-288.
40. Nagassaki S., Metzger I.F., Souza-Costa D.C., Marroni A.S., Uzuelli J.A., Tanus-Santos J.E. eNOS genotype is without effect on circulating nitrite/nitrate level in healthy male population. Thromb Res 2005, 115:375-379.
41. Veldman B.A., Spiering W., Doevendans P.A., Vervoort G., Kroon A.A., de Leeuw P.W., et al. The Glu298 Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J Hypertens 2002, 20:2023-2027.
42. Dhangadamajhi D., Mohapatra B.N., Kar S.K., Ranjit M. Endothelial nitric oxide synthase gene polymorphisms and plasmodium falciparum infection in Indian adults. Infect Immun 2009, 77:2943-2947.
43. Moon J., Yoon S., Kim E., Shin C., Jo S.A., Jo I. Lack of evidence for contribution of Glu298 Asp (894-G>T) polymorphism of endothelial nitric oxide synthase gene to plasma nitric oxide levels. Thromb Res 2002, 107:129-134.
44. Wang X.L., Mahaney M.C., Sim A.S., Wang J., Wang J., Blangero J., et al. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol 1997, 17:3147-3153.
45. Yoon S., Moon J., Shin C., Kim E., Jo S.A., Jo I. Smoking status-dependent association of the 27-bp repeat polymorphism in intron 4 of endothelial nitric oxide synthase gene with plasma nitric oxide concentrations. Clin Chim Acta 2002, 324:113-120.
46. Parle-McDermott A., Pangilinan F., Mills J.L., Kirke P.N., Gibney E.R., Troendle J., et al. The 19-bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR) may decrease rather than increase risk for spina bifida in the Irish population. Am J Med Genet A 2007, 143A:1174-1180.
47. Van der Linden I.J., Nguyen U., Heil S.G., Franke B., Vloet S., Gellekink H., et al. Variation and expression of dihydrofolate reductase (DHFR) in relation to spina bifida. Mol Genet Metab 2007, 91:98-103.
48. Kalmbach R.D., Choumenkovitch S.F., Troen A.P., Jacques P.F., D'Agostino R., Selhub J.A. 19-base pair deletion polymorphism in dihydrofolate reductase is associated with increased unmetabolized folic acid in plasma and decreased red Blood cell folate. J Nutr 2008, 138:2323-2327.
49. Sauberlich H.E., Kretsch M.J., Skala J.H., Johnson H.L., Taylor P.C. Folate requirement and metabolism in nonpregnant women. Am J Clin Nutr 1987, 46:1016-1028.